Showing 201-210 of 18558 results for "".
The Potential of Immunotherapy in Type 1 Diabetes
https://reachmd.com/programs/diabetes-discourse/the-potential-of-immunotherapy-in-type-1-diabetes/5111/Development of a combination therapy is showing significant promise in type 1 diabetes when caught in the early stages. What are some immuno-therapies currently being evaluated for treating type 1 diabetes? Join host Dr. Steven Edelman and his guest, director of the Center for Type 1 Diabetes ResearIdentification and Management of Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/identification-and-management-of-type-1-diabetes/308/Dr. Lori Laffel will discuss the increase in prevelence of Type 1 diabetes. She will also talk about the importance of glycemic control.Intensive Therapy for Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/intensive-therapy-for-type-1-diabetes/326/Dr. Lori Laffel, chief of the Pediatric and Adolescent Section at Joslin Clinic and an Investigator in the section on Genetics and Epidemiology at Joslin Diabetes Center as well as an Associate Professor of Pediatrics at Harvard Medical School discusses intesive therapy for Type 1 diabetes.Predicition and Prevention for Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/predicition-and-prevention-for-type-1-diabetes/1107/What causes type 1 diabetes? Are there predictors? Can the disease be delayed? What is currently being studied to prevent or cure diabetes and where are we at? In this segment Dr. Tamborlane addresses these issues and more.Immune Interventions for Type 1 Diabetes
https://reachmd.com/programs/diabetes-discourse/immune-interventions-for-type-1-diabetes/6171/Can immune intervention stop the disease process of type 1 diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine, pediatrics and psychology at the University of Miami, Dr. Jay Skyler, as they discuss the diagnosis, screening, testing and current immunotherapy research for the pEarly Indications of Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/early-indications-of-type-1-diabetes/3861/Type 1 diabetes has long been considered a disease of childhood and adolescence. However, current research suggests that infant nutrition, in addition to genetics and other factors early in life, can significantly impact a child's risk for developing the condition later in life. How can we identifyThe Hygiene Hypothesis and Risk of Type 1 Diabetes in Children
https://reachmd.com/programs/focus-on-diabetes/the-hygiene-hypothesis-and-risk-of-type-1-diabetes-in-children/6089/Improved living conditions and hygiene may be contributing to the rise of type 1 diabetes in children, but does the "hygiene hypothesis" fully explain the onset of type 1 diabetes in this population? What factors might explain the increased incidence of type 1 diabetes among pediatric patients in thInvestigating Type 1 Diabetes & Its Chronic Impacts
https://reachmd.com/programs/diabetes-discourse/investigating-type-1-diabetes-and-its-chronic-impacts/12232/How does type 1 diabetes impact the body over time?Type 1 Diabetes Research
https://reachmd.com/programs/clinicians-roundtable/type-1-diabetes-research/6848/Tune in to hear host Dr. Linda Bernstein spotlights type 1 diabetes and the new paradigms of research in disease detection, prevention and treatment.New Treatment Algorithm for Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/new-treatment-algorithm-for-type-2-diabetes/6178/The recent American Diabetes Association / European Association for the Study of Diabetes consensus panel produced their treatment algorithm to control glycaemia in type 2 diabetes. How can healthcare professionals treating patients with type 2 diabetes provide additional prandial intervention to re